Relating to designating Gabapentin as a monitored drug having a substantial potential for abuse.
hist134020Referred to the joint committee for review of Administrative Rules, May 12, 2021. PATRICK TESTIN
Chairperson
_____________
Messages from the Assembly
By Edward A. Blazel, chief clerk.
Mr. President:
I am directed to inform you that the Assembly has
Adopted and asks concurrence in:
Passed and asks concurrence in:
Concurred in:
/2021/related/journals/senate/20210512
true
journals
/2021/related/journals/senate/20210512/_41
journals/2021/hist133975
journals/2021/hist133975
section
true